Intra-Cellular Therapies

• 1/26/2025

  Johnson & Johnson’s Path to Long-Term Growth Amidst Challenges

• 1/23/2025

  J&J’s Mixed Quarter: Beating Expectations Amidst Growing Challenges

• 1/23/2025

  Johnson & Johnson Soars to New Heights: Q4 Sales and Profit Exceed Expectations

• 1/20/2025

  Johnson & Johnson’s Credit Rating Under Threat

• 1/16/2025

  Johnson & Johnson Boosts Neuro Treatment Portfolio with $14.6B Deal

• 1/14/2025

  Biotech Boom: J&J’s $14.6B Deal Sparks Industry Frenzy

• 1/14/2025

  $10 Billion Biotech Blockbuster: J&J Eyes Game-Changing Acquisition